ArticleCancer immunology, immunotherapy : CII2026
High PD-1 expression in pre-treatment peripheral lymphocytes associated with poor immune checkpoint inhibitor response in patients with recurrent or metastatic head and neck squamous cell carcinoma.
Shau-Hsuan Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.